New patent expiration for Genzyme drug MOZOBIL

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for MOZOBIL
Annual Drug Patent Expirations for MOZOBIL

Mozobil is a drug marketed by Genzyme and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for MOZOBIL.

This drug has forty-five patent family members in twenty-seven countries.

The generic ingredient in MOZOBIL is plerixafor. Two suppliers are listed for this compound. Additional details are available on the plerixafor profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top